-
Mashup Score: 4A pregnant Mexico City woman needed a new heart valve. Houston Methodist found a solution. - 2 month(s) ago
Houston Methodist performed its first TAVR surgery on a pregnant woman who needed a new heart valve due to severe aortic stenosis.
Source: www.houstonchronicle.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 7
AbstractBackgroundLeft ventricular outflow tract (LVOT) obstruction is a source of morbidity in hypertrophic cardiomyopathy (HCM) and a life-threatening complication of transcatheter mitral (TMVR) …
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
SESAME- Really innovative and disruptive technique- opening doors for HCM and TMVR patients by Dr Babaliaros @CathElectroSurg @AdamGreenbaumMD and team. Congrats. https://t.co/gscxWZSAUS @CRT_meeting #CRT24 https://t.co/2ccPhaU235
-
-
Mashup Score: 17The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today’s World? - 2 month(s) ago
Correspondence to: Neal S. Kleiman, MD, 6565 Fannin, MS WT-4-3020, Houston, TX 77030. Email Houston Methodist DeBakey Heart and Vascular Center, Houston, TX. Houston Methodist DeBakey Heart and Vascular Center, Houston, TX. The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. For Disclosures, see page 746. 1. Kapadia SR, Krishnaswamy A, Whisenant B, Potluri S, Iyer V, Aragon J, Gideon P, Strote J, Leonardi R, Agarwal H, et al. Circulation.
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today’s World? | Circulation https://t.co/FCsEHEurnv Editorial with Dr Neal Kleiman in @CircAHA on WATCH TAVR trial by @tavrkapadia et al
-
-
Mashup Score: 7Characteristics and Outcomes of Patients Ineligible for Tricuspid Transcatheter Edge-to-Edge Repair - 2 month(s) ago
Tricuspid transcatheter edge-to-edge repair (T-TEER) has emerged as a safe and effective therapy for patients with severe tricuspid regurgitation (TR).1 In The Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System (TRILUMINATE), T-TEER reduced TR severity and improved quality of life.1 Severe TR is associated with an increased risk of mortality and morbidity secondary to right ventricle (RV) failure and venous congestion.2 Despite T-TEER being an appealing therapy for patients with severe TR, not all patients screened are suitable candidates for T-TEER.
Source: www.structuralheartjournal.orgCategories: General Medicine News, CardiologistsTweet-
@OKhaliqueMD @purviparwani @djc795 @CathElectroSurg @ziadalinyc @onco_cardiology And tricuspid too!! https://t.co/HACUte7Epa
-
-
Mashup Score: 7Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement - 2 month(s) ago
Mitral transcatheter edge-to-edge repair (TEER) has proven to be a safe and effective treatment option in patients with primary mitral regurgitation (MR) at high or prohibitive surgical risk or those with secondary MR who remain symptomatic despite guideline-directed medical therapy (GDMT) and have favorable anatomy.1 Transcatheter mitral valve replacement (TMVR) is emerging as an important therapy for patients with symptomatic severe primary or secondary MR who are deemed high surgical risk and have unfavorable anatomy for TEER.
Source: www.structuralheartjournal.orgCategories: General Medicine News, CardiologistsTweet-
@Hragy Prevention is key. LVOTO risk is the main reason vast majority of patients are not TMVR candidates. TEER very effective and safe in appropriate FMR and DMR patients. We found >80% screen fail rate for TMVR https://t.co/IXgTwK0l99
-
-
Mashup Score: 3Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis - 3 month(s) ago
AbstractBackground and Aims. Residual leaks are not infrequent after left atrial appendage occlusion. However, there is still uncertainty regarding their progno
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet-
@OKhaliqueMD @ScrippsHealth @matthewjpricemd @DeeDeeWangMD @KKoulogiannis @HamidNadira @JoaoLCavalcante @onco_cardiology @purviparwani @DrRyanPDaly @StFrancis_LI Nice meta in EHJ showing larger the leak, higher the risk of adverse events https://t.co/4D3MCHd4KZ. We need data on steerable sheaths for coaxial implant to reduce any leak.
-
-
Mashup Score: 6Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis - 3 month(s) ago
Background: Large data comparing the performance of new-generation self-expandable versus balloon-expandable transcatheter heart valves in bicuspid aortic stenosis are lacking. We aim to compare the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
@djc795 @Umair2017 @jtsaxon @Adolfoferrero @BakhshiHooman @JingLiu_MD @BCMHeart @Almanfi_Cardio @SyedYNaqvi1 @patelapurva @ISeropianMD @oyvlie Here are some data comparing BE vs SE for bicuspid. All annular ruptures were in Sapien arm, none in Corevalve. https://t.co/GGVGghiRcn
-
-
Mashup Score: 7Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement - 3 month(s) ago
Mitral transcatheter edge-to-edge repair (TEER) has proven to be a safe and effective treatment option in patients with primary mitral regurgitation (MR) at high or prohibitive surgical risk or those with secondary MR who remain symptomatic despite guideline-directed medical therapy (GDMT) and have favorable anatomy.1 Transcatheter mitral valve replacement (TMVR) is emerging as an important therapy for patients with symptomatic severe primary or secondary MR who are deemed high surgical risk and have unfavorable anatomy for TEER.
Source: www.structuralheartjournal.orgCategories: General Medicine News, CardiologistsTweet-
@Hragy Prevention is key. LVOTO risk is the main reason vast majority of patients are not TMVR candidates. TEER very effective and safe in appropriate FMR and DMR patients. We found >80% screen fail rate for TMVR https://t.co/IXgTwK0l99
-
-
Mashup Score: 7Indication Creep in Transcatheter Aortic Valve Implantation - 4 month(s) ago
This Viewpoint discusses the expanded use of transcatheter aortic valve implantation in low-risk, younger patients.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet-
@djc795 @AndreaScotti21 @sbrugaletta @EuroInterventio @azeemlatib @MonteHeart @MontefioreNYC @EinsteinMed @DFCapodanno @ESC_Journals @SebLudwig1 @AugustinCoisne @guilbon @CurioJonathan @dmylotte @crfheart @GilbertTangMD @StevenYakubov @PinakShahMD @wfearonmd Multifactorial, in US: too many TAVR sites, everyone wants to do TAVR, industry likes more sites, patients want TAVR over SAVR (most frequent), doing procedures =more wRVU, docs forget which patients were excluded in TAVR trials https://t.co/CK1ud0O21y
-
-
Mashup Score: 5SCAI 2023 Scientific Sessions | SCAI - 1 year(s) ago
Every year, SCAI Scientific Sessions brings together the interventional cardiology community from around the world to share the latest clinical data, procedural guidance, and advanced expertise. Combining knowledge with insight and practical advice, the 2023 program will feature: Congenital, Coronary, Peripheral, Structural, and Cath Lab Management tracks Live cases Scientific and clinical…
Source: scai.orgCategories: Cardiologists, Latest HeadlinesTweet-
I’m looking forward to attending #SCAI2023 this May 18-20 as a @SCAI #SoMe Ambassador! Join me in #Phoenix for #InterventionalCardiology’s leading conference. Register here 📷 https://t.co/NlWprJJUvT https://t.co/dNt6ULW6AZ
-
@djc795 @biljana_parapid @ZainabDakhil2 @SarahFairley7 @Drroxmehran @ACUkaigweMD @UHhospitals @CRT_meeting @mmamas1973 @Marta33717088 @SrihariNaiduMD @SuzanneJBaron @AnkurKalraMD @DrMartaBande @ronwaksman @Pooh_Velagapudi @Hragy Saw 1, did TAVR https://t.co/64qRLlfLGq